Lotus seed resistant starch decreases the blood lipid and regulates the serum bile acids profiles in hyperlipidemic rats

Dietary resistant starch supplementation improves the fish growth, lipid metabolism and intestinal barrier in largemouth bass (Micropterus salmoides) fed high-fat diets

Resistant starch (RS) is a novel type of prebiotic that exerts positive effects on lipid metabolism and intestinal flora. In this study, we investigated the effects of dietary RS on lipid metabolism and the intestinal barrier in largemouth bass (Micropterus salmoides). The experimental fish were fed either a control diet (C), a high-fat diet (H), or H diets supplemented with 0.5 %, 1.5 %, and 3 % RS (HRS0.5, HRS1.5, and HRS3.0). Dietary supplementation with 1.5 % and 3.0 % RS increased the final weight and feed utilization. Moreover, the hepatic crude protein content and the expression of genes related to lipid lipolysis were significantly higher in the HRS1.5 group compared to the H group, whereas hepatic crude lipid content and the expression of genes related to lipid synthesis were considerably lower in the HRS1.5 and HRS3.0 groups than in the H group. Additionally, hepatocyte vacuolation was alleviated in the HRS1.5 and HRS3.0 groups, and the number of liver lipid droplets was significantly decreased. Dietary supplementation with 1.5 % and 3.0 % RS downregulated the expression of pro-inflammatory factors while upregulating the expression of anti-inflammatory factors. Furthermore, analysis of gut microbiota composition revealed that RS supplementation increased the population of beneficial bacteria and short-chain fatty acid (SCFA) contents, decreased the abundance of pathogenic bacteria, and enhanced the diversity and richness of the intestinal flora. Non-targeted metabolomics analysis indicated that the levels of L-arginine and betaine were significantly higher in the HRS1.5 group, while levels of L-methionine and taurocholic acid were notably elevated in the HRS3.0 group. In conclusion, dietary supplementation with 1.5-3.0 % RS improved the balance of intestinal flora, promoted the growth of beneficial bacteria, adjusted the metabolites profile, and increased the SCFA levels. These results suggest that dietary supplementation with 1.5-3.0 % RS can restore the intestinal protective barrier, reduce hepatic lipid accumulation, and regulate lipid metabolism in largemouth bass.

Type 3 resistant starch prepared from jackfruit alleviated the hyperlipidemia via gut microbiota regulation

Although resistant starch (RS) isolated from raw starch exhibits established regulatory effects on the mouse gut microbiota and associated hyperlipidemia, critical questions persist regarding RS in heated foods - the predominant form in the human diets, namely, the role of RS from heated food in the regulation of hyperlipidemia through gut microbiota is still unclear. This study evaluated the effects of a RS (jackfruit heated resistant starch, JFRS3) from heat-treated jackfruit native starch (JFNS) on hyperlipidemia in golden hamster gut microbes. Compared with JFNS, JFRS3 developed an irregular block-like shape with numerous grooves, exhibited more ordered structures (R1047/1022: 2.952 and R1022/995: 0.964) and greater crystallinity (relative crystallinity (RC): 21.96 %), and transformed into a C-type crystalline structure. Additionally, JFRS3 demonstrated significant antihyperlipidemic effects, which included an increase in high-density lipoprotein cholesterol (HDLC) levels (4.36 mmol/L) and reductions in triglyceride (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) levels (14.39, 4.55, and 4.61 mmol/L, respectively), thereby alleviating liver fatty lesions, reducing fat accumulation, and inhibiting adipocyte enlargement. These effects were closely linked to intestinal microbial changes, such as specific microbial enrichment and enhanced gut microbial diversity, potentially influenced by the structural properties of JFRS3. Furthermore, the consumption of JFRS3 was more effective in slowing weight gain and improving blood lipid profiles compared with raw RS present in JFNS. These findings prove that JFRS3 modulates hyperlipidemia induced by a high-fat diet and contributes to the development of alternative strategies for managing high-fat-diet-associated hyperlipidemia.

Gut microbiota-metabolic axis insight into the hyperlipidemic effect of lotus seed resistant starch in hyperlipidemic mice

We investigated the hyperlipidemic effect of different doses of lotus seed resistant starch (low-, medium and high-dose LRS, named as LLRS, MLRS and HLRS, respectively) in hyperlipidemic mice using gut microbiota-metabolic axis compared to high-fat diet mice (model control group, MC). Allobaculum was significantly decreased in LRS groups compared to MC group, while MLRS promoted the abundance of norank_f_Muribaculaceae and norank_f_Erysipelotrichaceae. Moreover, supplementation of LRS promoted cholic acid (CA) production and inhibited deoxycholic acid compared to MC group. Among, LLRS promoted formic acid, MLRS inhibited 20-Carboxy-leukotriene B4, while HLRS promoted 3, 4-Methyleneazelaic acid and inhibited Oleic acid and Malic acid. Finally, MLRS regulate microbiota composition, and this promoted cholesterol catabolism to form CA, which inhibited serum lipid index by gut microbiota-metabolic axis. In conclusion, MLRS can promote CA and inhibit medium chain fatty acids, so as to play the best role in lowering blood lipids in hyperlipidemia mice.